Abstract
The Soft Tissue and Bone Sarcoma Group (STBSG) is one of the 17 clinical cooperative groups of the European Organization for Research and Treatment of Cancer (EORTC). It was constituted in 1975 and increased from nine full members in 1976 to 21 full and 11 probational members from nine European countries by 1987.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
WHO. Handbook for Reporting Results of Cancer Treatment. WHO Offset Publication, Number 48, Geneva, 1979.
Pinedo HM, Bramwell VHC, Mouridsen HT, Somers R, Vendrik CPJ, Santoro A, Buesa J, Wagener Th, van Oosterom AT, van Unnik JAM, Sylvester R, De Pauw M, Thomas D, Bonadonna G: Cyvadic in advanced soft tissue sarcoma: a randomized study comparing two schedules. A study of the EORTC Soft Tissue and Bone Sarcoma Group. Cancer 53:1825–1832, 1984.
Gottlieb JA, Baker LH, O’Bryan RM, et al.: Adriamycin (NSC-123127) used alone and in combination for soft tissue and bone sarcomas. Cancer Chemother Rep 6:271–282, 1975.
Yap BS, Baker LH, Sinkovics JG, et al.: Cyclophosphamide, vincristine, adriamycin and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas. Cancer Treat Rep 64:93–98, 1980.
Bramwell VHC, Pinedo HM: Bone and soft tissue sarcomas. In HM Pinedo, (ed.): Cancer Chemotherapy. The EORTC Cancer Chemotherapy Annual 1. Excerpta Medica 1979:424–450.
Bramwell VHC, Pinedo HM: Bone and soft tissue sarcomas. In HM Pinedo (ed.): Cancer Chemotherapy. The EORTC Cancer Chemotherapy Annual 2. Excerpta Medica 1980:393–414.
Perevudchikova NI, Lichinityer MR, Gorbunova VA: Phase I clinical study of carminomycin: its activity against soft tissue sarcoma. Cancer Treat Rep 61:1705, 1977.
Bramwell VHC, Mouridsen HT, Mulder JH, Somers R, Van Oosterom AT, Santoro A, Thomas D, Sylvester R, Markham D: Carminomycin versus Adriamycin in advanced soft tissue sarcomas: an EORTC randomised phase II study. Eur J of Cancer and Clin Oncol 19:1097–1104, 1983.
Mouridsen HT, Somers R, Santoro A, Mulder JH, Bramwell V, Van Oosterom AT, Sylvester R, Thomas D, Pinedo HM: Doxorubicin versus epirubicin in advanced soft tissue sarcomas. An EORTC randomized phase II study. In. Advances in anthracycline chemotherapy: epirubicin. G. Bonadonna (Ed.), pp. 95–103, 1984. ISBN 88.214.1715.8.
Stuart-Harris RC, Harper PG, Parsons CA et al.: High dose alkylation therapy using Ifosfamide infusion with Mesna in the treatment of adult advanced soft tissue sarcoma. Cancer Chemother Pharm 11:69–72, 1983.
Bramwell VHC, Mouridsen HT, Santoro A, Blackledge G, Somers R, Verwey J, Dombernowsky P, Onsrud M, Thomas D, Sylvester R, Van Oosterom AT (for the European Organization for Research and Treatment of Cancer, Soft Tissue and Bone Sarcoma Group: Cyclophosphamide versus Ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas. Eur J Cancer and Clin Oncol 23:311–323, 1987.
Schütte J, Dombernowsky P, Santoro A, Stewart W, Mouridsen HT, Somers R, Van Oosterom AT, Blackledge G, Thomas D, Sylvester R (1986): Adriamycin (A) and ifosfamide (I), a new effective combination in advanced soft tissue sarcoma. Preliminary report of a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Proc Eur Conf Clin Oncol, 4:232, 1987.
Santoro A: Personal communication, 1987.
Bramwell VHC, Brugarolas A, Mouridsen HT, Cheix F, de Jager R, Van Oosterom AT, Vendrik CPJ, Pinedo HM, Sylvester R, De Pauw M: EORTC phase II study of Cisplatin in CyVADIC resistant soft tissue sarcomas. Eur J Cancer 15:1511–1513, 1979.
Mouridsen HT, Bramwell VHC, Lacave J, Metz R, Vendrik CPJ, Hild J, Mc Creanney J, Sylvester R: Treatment of advanced soft tissue sarcomas with chlorozotocin. a phase II trial of the EORTC Soft Tissue and Bone Sarcoma Group. Cancer Treat Rep 65:509–511, 1981.
Buesa JM, Mouridsen HT, Santoro A, Somers R, Bramwell V, Van Oosterom AT, Wagener Th, Vendrik C, Thomas D: Treatment of advanced soft tissue sarcomas with low-dose Methotrexate: a phase II trial by the European Organization for Research and Treatment of Cancer (EORTC) Soft Tissue and Bone Sarcoma Group, Cancer Treat Rep, 68:683, 1984.
Bramwell V, Van Oosterom AT, Mouridsen HT, Cheix F, Somers R, Thomas D, Rozencweig MN: -(Phosphonacetyl)-L-Aspartate (PALA) in advanced soft tissue sarcoma: a phase II trial of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer and Clin Oncol 18:81–84, 1982.
Somers R, Rouessé J, Van Oosterom AT, Thomas D: Phase II study of elliptinium in metastatic soft tissue sarcoma. Eur J Cancer Clin Oncol 21:591–593, 1985.
Van Oosterom AT, Santoro A, Bramwell V, Davy M, Mouridsen HT, Thomas D, Sylvester R: Mitomycin C (MMc) in advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer Clin Oncol 21:459–461, 1985.
Dombernowsky P, Buesa J, Pinedo HM, Santoro A, Mouridsen H, Somers R, Bramwell V, Onsrud M, Rouessé J, Thomas D, Sylvester R: VP 16 (Etoposide) in advanced soft tissue sarcoma: a phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Eur J Cancer Clin Oncol 23:579, 1987.
Blackledge G, Van Oosterom AT, Mouridsen HT, et al.: Treatment of advanced soft tissue sarcomas with adriamycin in second line. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group. Submitted for publication.
Buesa JM, Mouridsen H, Van Oosterom AT, Steward WT, Verwey J, Thomas D: High-dose DTIC in advanced soft-tissue sarcomas (STS) of the adult. A phase II study of the EORTC Soft-Tissue and Bone Sarcoma Group. Program and Abstracts, fifth NCI EORTC Symposium on new drugs in cancer therapy. Amsterdam nr. 2.20, 1986.
Rouessé J, Van Oosterom AT, Kerbrat P, Cappelaere P, Pinedo H, Thomas D, Benshahar D: Phase II study of 1,2,4 triglycidyl urasol (TGU) in advanced soft tissue sarcoma. A trial of EORTC’s Soft Tissue and Bone Sarcoma Cooperative Group. Eur J Cancer Clin Oncol 21:1413–1414, 1987.
Steward WP, Somers R, Kerbrat P, Verwey J, Buesa J, et al: Phase II study of Methyleen dimethane sulphonate (MDMS) in advanced soft tissue sarcomas of the adults. (in preparation).
Somers R: Personal communication.
Van Oosterom AT, Bramwell VHC, Mouridsen HT, Somers R, Santoro A, Buesa J, Vendrik CP, Rouessé J, Dombernowsky P, Pinedo HM, Thomas D, Sylvester R: Review of the EORTC Soft Tissue and Bone Sarcoma Group’s Phase II studies in advanced soft tissue sarcomas. In Management of Soft Tissue and Bone Sarcomas. Van Oosterom AT, van Unnik JAM (eds.), EORTC monograph, vol. 16, Raven Press, New York, pp. 161–167, 1986.
Verwey J: Personal communication.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Kluwer Academic Publishers
About this chapter
Cite this chapter
Van Oosterom, A.T. et al. (1988). Chemotherapy in Advanced Soft Tissue Sarcoma — The EORTC Experience. In: Ryan, J.R., Baker, L.O. (eds) Recent Concepts in Sarcoma Treatment. Developments in Oncology, vol 55. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-2691-2_28
Download citation
DOI: https://doi.org/10.1007/978-94-009-2691-2_28
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-010-7714-9
Online ISBN: 978-94-009-2691-2
eBook Packages: Springer Book Archive